These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10765417)

  • 1. A comparison of methods of benchmark-dose estimation for continuous response data.
    West RW; Kodell RL
    Risk Anal; 1999 Jun; 19(3):453-9. PubMed ID: 10765417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upper confidence limits on excess risk for quantitative responses.
    Kodell RL; West RW
    Risk Anal; 1993 Apr; 13(2):177-82. PubMed ID: 8502790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous confidence bounds for low-dose risk assessment with nonquantal data.
    Piegorsch WW; West RW; Pan W; Kodell RL
    J Biopharm Stat; 2005; 15(1):17-31. PubMed ID: 15702602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Model Uncertainty and Bayesian Model Averaged Benchmark Dose Estimation for Continuous Data.
    Shao K; Gift JS
    Risk Anal; 2014 Jan; 34(1):101-20. PubMed ID: 23758102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benchmark dose calculation for ordered categorical responses.
    Chen CC; Chen JJ
    Risk Anal; 2014 Aug; 34(8):1435-47. PubMed ID: 24444309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of three methods for calculating confidence intervals for the benchmark dose.
    Moerbeek M; Piersma AH; Slob W
    Risk Anal; 2004 Feb; 24(1):31-40. PubMed ID: 15027998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bootstrap estimation of benchmark doses and confidence limits with clustered quantal data.
    Zhu Y; Wang T; Jelsovsky JZ
    Risk Anal; 2007 Apr; 27(2):447-65. PubMed ID: 17511711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantalization of continuous data for benchmark dose estimation.
    Gaylor DW
    Regul Toxicol Pharmacol; 1996 Dec; 24(3):246-50. PubMed ID: 8975754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A semiparametric approach to risk assessment for quantitative outcomes.
    Bosch RJ; Wypij D; Ryan LM
    Risk Anal; 1996 Oct; 16(5):657-65. PubMed ID: 8962516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Confidence bands for low-dose risk estimation with quantal response data.
    Al-Saidy OM; Piegorsch WW; West RW; Nitcheva DK
    Biometrics; 2003 Dec; 59(4):1056-62. PubMed ID: 14969485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benchmark Dose Analysis via Nonparametric Regression Modeling.
    Piegorsch WW; Xiong H; Bhattacharya RN; Lin L
    Risk Anal; 2014 Jan; 34(1):135-51. PubMed ID: 23683057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating upper confidence limits for extra risk in quantal multistage models.
    Bailer AJ; Smith RJ
    Risk Anal; 1994 Dec; 14(6):1001-10. PubMed ID: 7846307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Benchmark experiment to verify radiation transport calculations for dosimetry in radiation therapy].
    Renner F
    Z Med Phys; 2016 Sep; 26(3):209-23. PubMed ID: 26422577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benchmark dose profiles for joint-action continuous data in quantitative risk assessment.
    Deutsch RC; Piegorsch WW
    Biom J; 2013 Sep; 55(5):741-54. PubMed ID: 23852573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simulation study of quantitative risk assessment for bivariate continuous outcomes.
    Yu ZF; Catalano PJ
    Risk Anal; 2008 Oct; 28(5):1415-30. PubMed ID: 18631306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-response assessments for developmental toxicity. IV. Benchmark doses for fetal weight changes.
    Kavlock RJ; Allen BC; Faustman EM; Kimmel CA
    Fundam Appl Toxicol; 1995 Jul; 26(2):211-22. PubMed ID: 7589910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An approach for modeling noncancer dose responses with an emphasis on uncertainty.
    Price PS; Keenan RE; Swartout JC; Gillis CA; Carlson-Lynch H; Dourson ML
    Risk Anal; 1997 Aug; 17(4):427-37. PubMed ID: 9323872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative risk assessment for multivariate continuous outcomes with application to neurotoxicology: the bivariate case.
    Yu ZF; Catalano PJ
    Biometrics; 2005 Sep; 61(3):757-66. PubMed ID: 16135027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interval estimation for Weibull-distributed life data under Type II progressive censoring with random removals.
    Tse SK; Xiang L
    J Biopharm Stat; 2003 Feb; 13(1):1-16. PubMed ID: 12635899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonparametric Bayesian methods for benchmark dose estimation.
    Guha N; Roy A; Kopylev L; Fox J; Spassova M; White P
    Risk Anal; 2013 Sep; 33(9):1608-19. PubMed ID: 23339666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.